Roupen Odabashian: Insightful talk on OncoDaily featuring Dr. Matteo Levisetti
“Had an insightful talk on OncoDaily featuring Dr. Matteo Levisetti, M.D. We discussed Cue Biopharma’s new drugs, their previous trials, future advancements, and Dr. Levisetti’s impressive career journey from physician to industry leader.”
Quoting OncoDaily’s post:
“Unlocking the Immune System: Dr. Matteo Levisetti, M.D. on Cue Biopharma’s New Biologics Roupen Odabashian MD, FRCPC, ABIM Karmanos Cancer Institute Pfizer”
Dr. Roupen Odabashian is an accomplished Internal Medicine Physician and Hematology/Oncology Fellow with a profound commitment to advancing healthcare through clinical practice, research, and technology. Currently based at the prestigious Karmanos Cancer Institute, Dr. Odabashian is actively involved in pioneering cancer treatments and conducting clinical research.
In addition to his clinical work, Dr. Odabashian is a multifaceted healthcare professional. He hosts podcast at OncoDaily, engaging with leading experts in oncology to share valuable insights with the medical community. Dr. Odabashian also contributes his expertise as an advisor at Spiraldot Health and Mesh AI, supporting innovative ventures in healthcare technology and collaborative scheduling to combat clinician burnout. With his diverse roles and unwavering dedication, Dr. Odabashian exemplifies a commitment to driving positive change in healthcare.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023